Evidence map›Paper›PMID 29563611›Full record

ArticleOncogene2018

HIPK2 and extrachromosomal histone H2B are separately recruited by Aurora-B for cytokinesis.

Laura Monteonofrio, Davide Valente, Manuela Ferrara, Serena Camerini, Roberta Miscione, Marco Crescenzi, Cinzia Rinaldo, Silvia Soddu

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. HIPK2 in the physiology of nervous system and its implications in neurological disorders.Biochimica et biophysica acta. Molecular cell research · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Laura MonteonofrioUnit of Cellular Networks and Molecular Therapeutic Targets, Regina Elena National Cancer Institute-IRCCS, Rome, 00144, Italy.
Davide ValenteUnit of Cellular Networks and Molecular Therapeutic Targets, Regina Elena National Cancer Institute-IRCCS, Rome, 00144, Italy.
Manuela FerraraInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), c/o Sapienza University, Rome, 00185, Italy.
Serena CameriniCore Facilities, Italian National Institute of Health, Rome, 00161, Italy.
Roberta MiscioneInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), c/o Sapienza University, Rome, 00185, Italy.
Marco CrescenziCore Facilities, Italian National Institute of Health, Rome, 00161, Italy.
Cinzia RinaldoUnit of Cellular Networks and Molecular Therapeutic Targets, Regina Elena National Cancer Institute-IRCCS, Rome, 00144, Italy. cinzia.rinaldo@uniroma1.it.
Silvia SodduUnit of Cellular Networks and Molecular Therapeutic Targets, Regina Elena National Cancer Institute-IRCCS, Rome, 00144, Italy. silvia.soddu@ifo.gov.it.
Istituti di Ricovero e Cura a Carattere Scientifico · ITNational Research Council · ITInstitute of Molecular Biology and Pathology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokinesis, the final phase of cell division, is necessary to form two distinct daughter cells with correct distribution of genomic and cytoplasmic materials. Its failure provokes genetically unstable states, such as tetraploidization and polyploidization, which can contribute to tumorigenesis. Aurora-B kinase controls multiple cytokinetic events, from chromosome condensation to abscission when the midbody is severed. We have previously shown that HIPK2, a kinase involved in DNA damage response and development, localizes at the midbody and contributes to abscission by phosphorylating extrachromosomal histone H2B at Ser14. Of relevance, HIPK2-defective cells do not phosphorylate H2B and do not successfully complete cytokinesis leading to accumulation of binucleated cells, chromosomal instability, and increased tumorigenicity. However, how HIPK2 and H2B are recruited to the midbody during cytokinesis is still unknown. Here, we show that regardless of their direct (H2B) and indirect (HIPK2) binding of chromosomal DNA, both H2B and HIPK2 localize at the midbody independently of nucleic acids. Instead, by using mitotic kinase-specific inhibitors in a spatio-temporal regulated manner, we found that Aurora-B kinase activity is required to recruit both HIPK2 and H2B to the midbody. Molecular characterization showed that Aurora-B directly binds and phosphorylates H2B at Ser32 while indirectly recruits HIPK2 through the central spindle components MgcRacGAP and PRC1. Thus, among different cytokinetic functions, Aurora-B separately recruits HIPK2 and H2B to the midbody and these activities contribute to faithful cytokinesis.

Indexed as

Aurora Kinase BCarrier ProteinsCell Cycle ProteinsCell Line, TumorChromosomal InstabilityCytokinesisDNA-Binding ProteinsGTPase-Activating ProteinsHCT116 CellsHeLa CellsHistonesHumansProtein Serine-Threonine KinasesRNA InterferenceRNA, Small InterferingAURKB protein, humanAurora Kinase BCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsGTPase-Activating ProteinsHIPK2 protein, humanHistonesmgcRacGAPPRC1 protein, humanProtein Serine-Threonine KinasesRNA, Small Interfering

Identifiers

PMID29563611
PMCPMC6021368
OpenAlexW2796420249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.